FOXP4
Basic information
Region (hg38): 6:41546381-41602384
Links
Phenotypes
GenCC
Source:
- complex neurodevelopmental disorder (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FOXP4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 42 | 46 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 5 | |||||
Total | 0 | 1 | 51 | 2 | 6 |
Variants in FOXP4
This is a list of pathogenic ClinVar variants found in the FOXP4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-41546996-G-C | Lung adenocarcinoma | Uncertain significance (Jun 06, 2022) | ||
6-41547096-T-C | Lung adenocarcinoma | Uncertain significance (Jun 06, 2022) | ||
6-41565584-C-A | Lung adenocarcinoma | Uncertain significance (Jun 06, 2022) | ||
6-41565770-G-T | Likely pathogenic (Dec 03, 2023) | |||
6-41565807-G-A | not specified | Uncertain significance (Aug 23, 2021) | ||
6-41565818-G-A | not specified | Uncertain significance (Jun 06, 2023) | ||
6-41565835-G-A | Benign (Jun 22, 2021) | |||
6-41565841-C-A | Benign (Jun 22, 2021) | |||
6-41565857-G-A | Likely benign (Feb 01, 2024) | |||
6-41565864-C-T | not specified | Uncertain significance (Aug 30, 2021) | ||
6-41565885-C-T | not specified | Uncertain significance (Jun 07, 2023) | ||
6-41565890-A-G | not specified | Uncertain significance (Nov 25, 2024) | ||
6-41565894-A-G | not specified | Uncertain significance (Dec 19, 2022) | ||
6-41565951-TC-T | Uncertain significance (Aug 24, 2018) | |||
6-41565953-C-T | FOXP4-related disorder | Uncertain significance (Jun 19, 2023) | ||
6-41578002-G-A | not specified | Uncertain significance (Oct 02, 2023) | ||
6-41578050-A-G | not specified | Uncertain significance (Oct 07, 2024) | ||
6-41578070-T-C | not specified | Uncertain significance (Jun 16, 2024) | ||
6-41584841-C-T | Uncertain significance (Jul 15, 2024) | |||
6-41584882-G-GC | Neurodevelopmental disorder | Uncertain significance (Oct 08, 2024) | ||
6-41585463-G-A | Benign/Likely benign (Feb 01, 2023) | |||
6-41585475-G-T | not specified | Uncertain significance (Jun 11, 2021) | ||
6-41586795-T-C | Lung adenocarcinoma | Uncertain significance (Jun 06, 2022) | ||
6-41586868-G-T | Lung adenocarcinoma | Uncertain significance (Jun 06, 2022) | ||
6-41587084-A-C | Uncertain significance (Jan 25, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FOXP4 | protein_coding | protein_coding | ENST00000373060 | 16 | 55959 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.982 | 0.0176 | 125737 | 0 | 8 | 125745 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.95 | 304 | 416 | 0.731 | 0.0000258 | 4361 |
Missense in Polyphen | 95 | 163.72 | 0.58027 | 1737 | ||
Synonymous | -0.651 | 197 | 186 | 1.06 | 0.0000131 | 1363 |
Loss of Function | 4.64 | 5 | 34.4 | 0.146 | 0.00000147 | 367 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000868 | 0.0000868 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000266 | 0.0000264 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000328 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional repressor that represses lung-specific expression. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.153
Intolerance Scores
- loftool
- 0.0749
- rvis_EVS
- -0.95
- rvis_percentile_EVS
- 9.27
Haploinsufficiency Scores
- pHI
- 0.553
- hipred
- Y
- hipred_score
- 0.735
- ghis
- 0.545
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.973
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Foxp4
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; respiratory system phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II
- Cellular component
- nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;protein binding;sequence-specific DNA binding;metal ion binding